New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 22, 2013
09:21 EDTNF, VVUS, KKR, GDI, TASR, BLOX, FIRE, ARUN, WBMD, DRI, WIFIOn The Fly: Pre-market Movers
UP AFTER EARNINGS/GUIDANCE: WebMD (WBMD), up 20.5%... Aruba Networks (ARUN), up 13.5%... SourceFire (FIRE), 13.9%... Infoblox (BLOX), up 10.2%... Hewlett-Packard (HPQ), up 4.3%... AIG (AIG), 5.3%... Darden (DRI), up 0.5%... ALSO HIGHER: TASER (TASR), up 5.8% following upgrade to Overweight at JPMorgan... Gardner Denver (GDI), up 4.8% after quarterly report, Bloomberg says KKR (KKR) makes $75 per share takeover bid... DOWN AFTER EARNINGS/GUIDANCE: Boingo Wireless (WIFI), down 22.7%... Abercrombie & Fitch (ANF), down 0.8%... ALSO LOWER: Vivus (VVUS), down 3.6% after European regulator confirms rejection of Qsiva application.
News For NF;DRI;WBMD;ARUN;FIRE;BLOX;TASR;GDI;KKR;VVUS;WIFI From The Last 14 Days
Check below for free stories on NF;DRI;WBMD;ARUN;FIRE;BLOX;TASR;GDI;KKR;VVUS;WIFI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
September 12, 2014
07:04 EDTDRIDarden reports Q1 Olive Garden's sales down 0.5% to $913.5M
Subscribe for More Information
07:03 EDTDRIDarden reports Q1 LongHorn Steakhouse same-restaurant sales up 2.8%
Subscribe for More Information
07:01 EDTDRIDarden reports Q1 adjusted EPS 32c, consensus 32c
Subscribe for More Information
06:09 EDTDRIStarboard releases detailed transformation plan for Darden
Subscribe for More Information
September 11, 2014
18:07 EDTARUNAruba Networks initiated with an Equal Weight at Morgan Stanley
15:10 EDTDRIDarden technical comments before earnings
Subscribe for More Information
15:10 EDTDRINotable companies reporting before tomorrow's open
Subscribe for More Information
12:42 EDTVVUSOrexigen falls after FDA requires warnings on Contrave label
Subscribe for More Information
10:59 EDTVVUSArena competition picks up after Contrave approval, says Piper Jaffray
Subscribe for More Information
08:01 EDTVVUSOrexigen Contrave could have stronger launch than peers, says Wells Fargo
After the FDA approved Orexigen's (OREX) Contrave as a treatment option for chronic weight management, Wells Fargo does not believe the label included any significant surprises. The firm thinks multiple factors increase the chances that Contrave's launch will be stronger than two other weight loss drugs that were launched in recent years by VIVUS and Arena Pharmaceuticals (ARNA). The firm keeps an Outperform rating on Orexigen.
September 10, 2014
17:49 EDTDRIStarboard Value says Darden has not fully complied with Florida courtís order
Subscribe for More Information
11:03 EDTKKRKKR management to meet with JMP Securities
Meeting to be held in New York on September 16 hosted by JMP Securities.
10:32 EDTTASRTASER management to meet with Oppenheimer
Subscribe for More Information
10:06 EDTTASRTASER has a conference call hosted by JPMorgan
Subscribe for More Information
09:07 EDTDRIDarden Restaurants volatility elevated into Q2 and growth outlook
Subscribe for More Information
07:04 EDTWBMDWebMD announces preliminary results of tender offer
WebMD Health announced the preliminary results of its tender offer to purchase up to 2,000,000 shares of its common stock at a price of $48.50 per share, which expired at 5:00 p.m., New York City time, on September 9. Based on the preliminary count by American Stock Transfer & Trust Company, the Depositary for the tender offer, approximately 6.3 million shares of common stock were properly tendered and not withdrawn, including: approximately 1.3 million shares that were tendered through notice of guaranteed delivery; and approximately 1.1 million shares that were conditionally tendered by stockholders and for which the determination whether the applicable conditions were met will be made following the verification process described below. Accordingly, WebMD expects to accept for purchase a total of 2,000,000 shares at a purchase price of $48.50 per share, for an aggregate purchase price of $97M. Since the offer was oversubscribed, the number of shares that WebMD will purchase from each tendering shareholder will be pro-rated. Based upon the preliminary count and including all shares conditionally tendered, WebMD estimates that the pro-ration factor would be approximately 31.5%.
06:23 EDTKKRUniCredit head sees loan project completion by end of FY14, Reuters says
Unicredit (UNCFF) CEO Federico Ghizzoni is anticipating a restructured loans project having to do with domestic competitor Intesa Sanpaolo (ISNPY) and KKR (KKR) to be finished by the end of FY14, according to Reuters, citing comments from Ghizzoni. Reference Link
September 9, 2014
12:46 EDTVVUSNovo Nordisk weight loss drug helped people get thinner, Bloomberg reports
Subscribe for More Information
08:34 EDTWBMDWebMD to benefit from Apple initiatives, says RBC Capital
RBC Capital expects WebMD (WBMD) to benefit from Apple's (AAPL) launch of initiatives in the consumer health IT market. The firm believes that Apple's efforts in this area will provide more publicity for WebMD. RBC Capital keeps a $70 price target and Top Pick rating on WebMD.
08:23 EDTKKRU.S. Treasury Dept and U.S. Transportation Dept to co-host a summit
Infrastructure Investment Summit to be held in Washington, D.C. on September 9 with webcasted presentations to begin at 8:30 am. Webcast Link
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use